Free Daily Biotech Industry Newsletter
Get the latest on Biotech & Pharma Deals, Clinical Trials, FDA Decisions, and Key Regulatory Issues sent straight to your Inbox. Join over 150,000 biotech professionals who subscribe to FierceBiotech for FREE!
After years of FDA chidings and resultant drug shortages, Boehringer Ingelheim is pulling the plug on its Ben Venue contract manufacturing business by the end of the year, planning to lay off 1,100 workers. Article
| December 2, 2015 | 10am ET / 7am PT | Presented By: PerkinElmer
The goals of translational R&D have placed a particular premium on the ability to rapidly collect, curate, and integrate information from a variety of sources. This presentation will discuss some of the challenges in building a sustainable technology infrastructure to support these activities, which will enable more sophisticated analytics and decision support. Reserve Your Spot Today!
FierceBiotech monitors biotech & pharma deals, FDA decisions, clinical trials, and more. Join more than 150,000 biotech industry leaders who subscribe to our free daily email. Click here to get your free weekly email briefing today!